Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses
Judith M. White, Joshua T. Schiffer, Rachel Bender Ignacio, et al.
mBio (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
Aleksandr Ianevski, Anil K Giri, Tero Aittokallio
Nucleic Acids Research (2022) Vol. 50, Iss. W1, pp. W739-W743
Open Access | Times Cited: 385
SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination
Pengfei Li, Yining Wang, Marla Lavrijsen, et al.
Cell Research (2022) Vol. 32, Iss. 3, pp. 322-324
Open Access | Times Cited: 193
Deep learning in drug discovery: an integrative review and future challenges
Heba Askr, Enas Elgeldawi, Heba Aboul Ella, et al.
Artificial Intelligence Review (2022) Vol. 56, Iss. 7, pp. 5975-6037
Open Access | Times Cited: 183
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 96
Lassa fever — the road ahead
Robert F. Garry
Nature Reviews Microbiology (2022) Vol. 21, Iss. 2, pp. 87-96
Open Access | Times Cited: 90
A dual graph neural network for drug–drug interactions prediction based on molecular structure and interactions
Mei Ma, Xiujuan Lei
PLoS Computational Biology (2023) Vol. 19, Iss. 1, pp. e1010812-e1010812
Open Access | Times Cited: 43
In Silico Repurposed Drugs against Monkeypox Virus
Hilbert Yuen In Lam, Jia Sheng Guan, Yuguang Mu
Molecules (2022) Vol. 27, Iss. 16, pp. 5277-5277
Open Access | Times Cited: 63
Discovery of Amphiphilic Xanthohumol Derivatives as Membrane-Targeting Antimicrobials against Methicillin-Resistant Staphylococcus aureus
Wanqing Cheng, Ting Xu, Liping Cui, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 962-975
Closed Access | Times Cited: 41
The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro
Anna Gidari, Samuele Sabbatini, Elisabetta Schiaroli, et al.
Microorganisms (2022) Vol. 10, Iss. 7, pp. 1475-1475
Open Access | Times Cited: 40
Systematic review of computational methods for drug combination prediction
Weikaixin Kong, Gianmarco Midena, Yingjia Chen, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 2807-2814
Open Access | Times Cited: 39
Viral Membrane Fusion: A Dance Between Proteins and Lipids
Judith M. White, Amanda E. Ward, Laura Odongo, et al.
Annual Review of Virology (2023) Vol. 10, Iss. 1, pp. 139-161
Open Access | Times Cited: 37
The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants
Aleksandr Ianevski, Irene Trøen Frøysa, Hilde Lysvand, et al.
Antiviral Research (2024) Vol. 224, pp. 105842-105842
Open Access | Times Cited: 9
Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2
Jessica Wagoner, Shawn Herring, Tien-Ying Hsiang, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 36
Mono- and combinational drug therapies for global viral pandemic preparedness
Aleksandr Ianevski, Rouan Yao, Ronja M. Simonsen, et al.
iScience (2022) Vol. 25, Iss. 4, pp. 104112-104112
Open Access | Times Cited: 30
SLiM-binding pockets: an attractive target for broad-spectrum antivirals
Leandro Simonetti, Jakob Nilsson, Gerald M. McInerney, et al.
Trends in Biochemical Sciences (2023) Vol. 48, Iss. 5, pp. 420-427
Open Access | Times Cited: 20
Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antivirals
Jimena Pérez‐Vargas, Gabriel Lemieux, Connor A.H. Thompson, et al.
Antiviral Research (2024) Vol. 225, pp. 105869-105869
Open Access | Times Cited: 6
What are the current challenges for machine learning in drug discovery and repurposing?
Tero Aittokallio
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 5, pp. 423-425
Open Access | Times Cited: 27
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform
Denisa Bojková, Philipp Reus, Leona Panosch, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 105944-105944
Open Access | Times Cited: 16
Synergistic Activity of Remdesivir–Nirmatrelvir Combination on a SARS-CoV-2 In Vitro Model and a Case Report
Anna Gidari, Samuele Sabbatini, Elisabetta Schiaroli, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1577-1577
Open Access | Times Cited: 15
Predicting the Anti-SARS-CoV-2 Potential of Isoquinoline Alkaloids from Brazilian Siparunaceae Species Using Chemometric Tools
Brendo Araújo Gomes, Diégina Araújo Fernandes, Simony Carvalho Mendonça, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 633-633
Open Access
Synergistic combination of orally available safe-in-man pleconaril, AG7404, and mindeudesivir inhibits enterovirus infections in human cell and organoid cultures
Erlend Ravlo, Aleksandr Ianevski, Jørn-Ove Schjølberg, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Inhaled Dry Powder of Antiviral Agents: A Promising Approach to Treating Respiratory Viral Pathogens
Tushar Saha, Zia Uddin Masum, Anik Naha Biswas, et al.
Viruses (2025) Vol. 17, Iss. 2, pp. 252-252
Open Access
Computational drug repurposing: approaches, evaluation of in silico resources and case studies
Ziaurrehman Tanoli, Adrià Fernández‐Torras, Umut Onur Özcan, et al.
Nature Reviews Drug Discovery (2025)
Closed Access
Computational Approaches in the Discovery and Development of Therapeutic and Prophylactic Agents for Viral Diseases
Anand Gaurav, Neetu Agrawal, Mayasah Al‐Nema, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 26, pp. 2190-2206
Closed Access | Times Cited: 17
Seven classes of antiviral agents
Aleksandr Ianevski, Shahzaib Ahmad, Kraipit Anunnitipat, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 12
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top